Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRICKLE2 antisense RNA 1 (PRICKLE2-AS1) is a human long non-coding RNA (lncRNA), meaning it is transcribed from the genome but does not encode a protein[1][5][6]. It is located on chromosome 3 (chr3:64024107-64103131, hg38)[1]. PRICKLE2-AS1 has been associated with epigenetic and transcriptional regulation through differential methylation patterns, particularly in certain cancers such as vulvar squamous cell carcinoma[4]. There are currently no known direct interacting drugs or established therapeutic targeting mechanisms for PRICKLE2-AS1, and it is not classified as a canonical therapeutic target such as a receptor, enzyme, transporter, or similar protein[1][5]. The main functional roles and disease associations are currently inferred from its encoded gene's expression profiles and observed differential methylation, suggesting a potential but as yet uncharacterized role in gene regulation and disease[2][4]. There is no evidence for PRICKLE2-AS1 being a misannotated or incorrect target—it is a valid lncRNA gene with supporting genomic and functional association data[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRICKLE2 antisense RNA 1 (PRICKLE2-AS1).